Bio-Path Holdings, Inc. (BPTH)
BPTH Stock Price Chart
Explore Bio-Path Holdings, Inc. interactive price chart. Choose custom timeframes to analyze BPTH price movements and trends.
BPTH Company Profile
Discover essential business fundamentals and corporate details for Bio-Path Holdings, Inc. (BPTH) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
4 Mar 2008
Employees
10.00
Website
https://www.biopathholdings.comCEO
Peter H. Nielsen MBA
Description
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing Liposomal Bcl-2 for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; Liposomal STAT3 that is in preclinical stage for the treatment of pancreatic cancer, non-small cell lung cancer, and AML; and prexigebersen-A for various solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Bellaire, Texas.
BPTH Financial Timeline
Browse a chronological timeline of Bio-Path Holdings, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 May 2026
Upcoming earnings on 25 Mar 2026
Upcoming earnings on 13 Nov 2025
EPS estimate is -$0.40.
Earnings released on 14 Aug 2025
EPS came in at -$0.55 falling short of the estimated -$0.40 by -37.50%.
Earnings released on 15 May 2025
EPS came in at -$0.40 falling short of the estimated -$0.38 by -5.26%.
Earnings released on 27 Mar 2025
EPS came in at -$0.07 surpassing the estimated -$0.37 by +81.08%.
Earnings released on 14 Nov 2024
EPS came in at -$0.87 surpassing the estimated -$1.02 by +14.71%.
Earnings released on 15 Aug 2024
EPS came in at -$1.16 surpassing the estimated -$1.54 by +24.68%.
Earnings released on 15 May 2024
EPS came in at -$4.88 falling short of the estimated -$4.54 by -7.49%.
Earnings released on 8 Mar 2024
EPS came in at -$7.05 falling short of the estimated -$5.40 by -30.56%, while revenue for the quarter reached $274.00K .
Stock split effective on 23 Feb 2024
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 Nov 2023
EPS came in at -$6.40 surpassing the estimated -$6.80 by +5.88%.
Earnings released on 15 Aug 2023
EPS came in at -$10.60 falling short of the estimated -$10.40 by -1.92%.
Earnings released on 31 Mar 2023
EPS came in at -$10.60 falling short of the estimated -$9.00 by -17.78%.
Earnings released on 23 Mar 2023
EPS came in at -$9.51 falling short of the estimated -$0.46 by -1.97K%.
Earnings released on 15 Nov 2022
EPS came in at -$9.80 falling short of the estimated -$9.20 by -6.52%.
Earnings released on 15 Aug 2022
EPS came in at -$8.40 surpassing the estimated -$10.00 by +16.00%.
Earnings released on 16 May 2022
EPS came in at -$9.40 falling short of the estimated -$9.20 by -2.17%.
Earnings released on 11 Mar 2022
EPS came in at -$11.80 falling short of the estimated -$6.40 by -84.38%.
Earnings released on 10 Nov 2021
EPS came in at -$5.80 surpassing the estimated -$6.60 by +12.12%.
Earnings released on 13 Aug 2021
EPS came in at -$5.20 surpassing the estimated -$8.00 by +35.00%.
Earnings released on 14 May 2021
EPS came in at -$8.60 surpassing the estimated -$10.00 by +14.00%.
Earnings released on 10 Mar 2021
EPS came in at -$11.40 surpassing the estimated -$15.60 by +26.92%.
Earnings released on 13 Nov 2020
EPS came in at -$16.00 surpassing the estimated -$16.60 by +3.61%.
BPTH Stock Performance
Access detailed BPTH performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.